Sabinsa’s Tips for Choosing Ingredients for Women’s Wellness

Sponsored by Sabinsa

Beauty-from-within is no longer just an emerging trend. It's becoming a defining category in women's wellness, and Sabinsa has helped shape this space for more than 35 years. In this video, Kavita Subramanian, Senior Manager of International Business at Sabinsa, draws on the company's expertise in standardized botanical extracts to address a challenge every formulator faces: selecting ingredients that deliver measurable benefits and are supported by rigorous scientific evidence. She explains how the industry has evolved beyond topical cosmetics to embrace oral nutricosmetic ingredients that support skin and hair health from within—and why today's consumers increasingly expect products backed by clinical research and transparent quality standards.

Subramanian highlights four of Sabinsa's standardized oral nutricosmetic ingredients developed for women's wellness. Saberry® is a standardized amla extract rich in naturally occurring antioxidants that supports skin brightening and protection. Cococin™ is derived from tender coconut water and provides hydration along with naturally occurring micronutrients. Curcumin C3 Reduct® is a standardized tetrahydrocurcuminoid ingredient containing the major metabolites of curcumin, designed to deliver the bioactive compounds the body naturally forms from curcumin. Silbinol® is a pterostilbene ingredient recognized for its enhanced stability and bioavailability compared with resveratrol. Throughout the discussion, Subramanian contrasts rigorously standardized botanical extracts with simple ratio extracts, such as 10:1 extracts, noting that extraction ratios alone reveal little about active compound content or batch-to-batch consistency. Instead, standardized ingredients characterized by defined marker compounds, comprehensive analytical testing, and human clinical research provide formulators with meaningful evidence to support product quality and performance.

For brands focused on transparency, quality, and regulatory compliance, Subramanian emphasizes the importance of published clinical data, robust analytical methods, and detailed Certificates of Analysis when evaluating botanical suppliers. She points to Curcumin C3 Reduct®, which received authorization in the European market following EFSA's Novel Food evaluation, as an example of how independent regulatory review can strengthen product credibility and support responsible marketing. Formulators, brand owners, and product developers seeking to build differentiated women's wellness products with clinically supported botanical ingredients will gain practical guidance on evaluating ingredient quality, asking the right questions of suppliers, and selecting partners committed to scientific rigor.